Shree Hari Chemicals Export Ltd Valuation Shifts Signal Changing Market Sentiment

Valuation Metrics and Recent Changes

As of 26 Aug 2026, Shree Hari Chemicals Export Ltd trades at a price of ₹167.80, up 4.97% from the previous close of ₹159.85. The stock has seen a strong upward trajectory over the past year, with a 1-year return of 59.73%, substantially outperforming the Sensex, which declined by 4.88% over the same period. Over a longer horizon, the stock’s 3-year return stands at an impressive 262.58%, dwarfing the Sensex’s 19.68% gain.

Despite this strong price performance, the company’s valuation grade has shifted from fair to expensive, signalling a re-rating by the market. The price-to-earnings (P/E) ratio currently stands at 9.05, which, while modest in absolute terms, is considered expensive relative to the company’s historical valuation and peer group.

The price-to-book value (P/BV) ratio is 2.39, indicating that the stock is trading at more than twice its book value. Other valuation multiples include an EV/EBITDA of 8.03 and an EV/EBIT of 9.48, both suggesting a premium valuation compared to historical averages for the company.

Peer Comparison Highlights Valuation Premium

When compared with peers in the commodity chemicals industry, Shree Hari Chemicals Export Ltd’s valuation appears relatively attractive on some fronts but expensive on others. For instance, J.G. Chemicals trades at a P/E of 30.28 and EV/EBITDA of 22.18, both significantly higher than Shree Hari Chemicals. Similarly, Titan Biotech and Indo Borax & Chemicals are rated very expensive with P/E ratios of 46.38 and 31.8 respectively, and EV/EBITDA multiples above 25.

However, some peers such as I G Petrochemicals and Keltech Energies also command very expensive valuations, with P/E ratios of 18.35 and 56.3 respectively. This context suggests that while Shree Hari Chemicals is expensive relative to its own past, it remains competitively valued within its sector, especially given its micro-cap status and growth trajectory.

Financial Performance and Quality Metrics

Shree Hari Chemicals’ return on capital employed (ROCE) is 6.07%, and return on equity (ROE) is 9.30%. These figures, while moderate, reflect steady operational efficiency and profitability. The company’s PEG ratio is exceptionally low at 0.06, indicating that the stock’s price growth is not yet fully justified by earnings growth, which could imply further upside potential if earnings catch up.

Dividend yield data is not available, which is typical for companies in growth phases or micro-cap segments reinvesting earnings for expansion.

Price Performance Versus Market Benchmarks

The stock’s recent price action has been robust, with a 1-month return of 24.34% compared to the Sensex’s 2.10%. Year-to-date, Shree Hari Chemicals has gained 28.09%, while the Sensex has declined by 8.88%. This outperformance highlights strong investor interest and confidence in the company’s prospects.

Over five and ten-year periods, the stock has delivered returns of 179.90% and 95.34% respectively, compared to the Sensex’s 38.81% and 178.98%. The 10-year comparison shows the broader market’s strength, but the company’s shorter-term momentum remains compelling.

Valuation Grade Upgrade and Market Implications

On 17 Aug 2026, the company’s Mojo Grade was upgraded from Hold to Buy, with a Mojo Score of 71.0. This upgrade reflects improved market sentiment and recognition of the company’s growth potential despite the elevated valuation. The micro-cap classification underscores the stock’s higher risk-return profile, appealing to investors seeking growth opportunities in niche commodity chemical segments.

Investors should note that the shift from fair to expensive valuation grade signals a need for caution. While the stock remains attractively priced relative to some peers, the premium multiples suggest that future returns will depend heavily on continued earnings growth and operational execution.

Sector and Industry Context

The commodity chemicals sector is characterised by cyclical demand and pricing volatility. Shree Hari Chemicals’ valuation premium may reflect expectations of sustained demand growth or improved cost efficiencies. However, investors must weigh these prospects against sector headwinds such as raw material price fluctuations and regulatory changes.

Comparative analysis with peers like J.G. Chemicals and Titan Biotech reveals a wide valuation dispersion within the sector, indicating varying investor perceptions of growth and risk. Shree Hari Chemicals’ relatively moderate P/E and EV/EBITDA ratios suggest it is positioned between the extremes of very expensive and fair valuations.

Investor Takeaways and Outlook

Shree Hari Chemicals Export Ltd’s valuation shift from fair to expensive reflects a market reassessment of its growth prospects and risk profile. The company’s strong price performance and upgraded Mojo Grade to Buy support a positive outlook, but the premium multiples warrant careful monitoring of earnings delivery.

Investors should consider the company’s valuation in the context of its micro-cap status, sector dynamics, and peer valuations. The low PEG ratio suggests potential for earnings growth to justify current prices, but any slowdown in growth or sector headwinds could pressure the stock’s premium rating.

Overall, Shree Hari Chemicals remains an attractive proposition for investors seeking exposure to the commodity chemicals sector with a growth bias, provided they are comfortable with the valuation premium and associated risks.

Summary of Key Financial Metrics

Price: ₹167.80 | P/E Ratio: 9.05 | P/BV: 2.39 | EV/EBITDA: 8.03 | ROCE: 6.07% | ROE: 9.30% | PEG Ratio: 0.06 | Market Cap Grade: Micro-cap | Mojo Score: 71.0 (Buy)

Conclusion

Shree Hari Chemicals Export Ltd’s recent valuation upgrade and strong price momentum highlight its evolving market perception. While the stock is now rated expensive, it remains competitively valued within its sector and offers compelling growth potential. Investors should balance the valuation premium against the company’s operational metrics and sector outlook to make informed decisions.

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →